High dose intravenous immunoglobulin treatment: Mechanisms of action

被引：44
作者：
Boros, P
Gondolesi, G
Bromberg, AS
机构：
[1] Mt Sinai Sch Med, Recanati Miller Transplantat Inst, New York, NY 10029 USA
[2] Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY USA
来源：
LIVER TRANSPLANTATION | 2005年 / 11卷 / 12期
关键词：
D O I：
10.1002/lt.20594
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Intravenous immunoglobulin (IVIg) treatment was introduced as replacement therapy for patients with antibody deficiencies, but evidence suggests that a wide range of immune-mediated conditions could benefit from IVIg. The immunoglobulins are precipitated from human plasma by fractionation methods. In conclusion, the differences in basic fractionation methods and the addition of various modifications for purification, stabilization, and virus inactivation result in products significantly different from each other.
引用
收藏
页码：1469 / 1480
页数：12
相关论文
共 109 条
  • [71] A new strategy for the prevention of IgA anaphylactic transfusion reactions
    Salama, A
    Temmesfeld, B
    Hippenstiel, S
    Kalus, U
    Suttorp, N
    Kiesewetter, H
    [J]. TRANSFUSION, 2004, 44 (04) : 509 - 511
  • [72] Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor
    Samuelsson, A
    Towers, TL
    Ravetch, JV
    [J]. SCIENCE, 2001, 291 (5503) : 484 - 486
  • [73] Savasman C M, 2001, Immunohematology, V17, P106
  • [74] Scheinecker C, 2001, ARTHRITIS RHEUM, V44, P856, DOI 10.1002/1529-0131(200104)44:4<856::AID-ANR142>3.3.CO
  • [75] 2-1
  • [76] Human immunoglobulins inhibit thrombin-induced Ca2+ movements and nitric oxide production in endothelial cells
    Schussler, O
    Lantoine, F
    Devynck, MA
    Glotz, D
    DavidDufilho, M
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (43) : 26473 - 26476
  • [77] Intravenous immunoglobulins for therapeutic use contain anti-idiotypes against xenophile antibodies and prolong discordant graft survival
    Schussler, O
    Genevaz, D
    Latremouille, C
    Goussev, N
    Kaveri, S
    Glotz, D
    [J]. CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1998, 86 (02): : 183 - 191
  • [78] IV immunoglobulin reduces circulating proinflammatory cytokines in Guillain-Barre syndrome
    Sharief, MK
    Ingram, DA
    Swash, M
    Thompson, EJ
    [J]. NEUROLOGY, 1999, 52 (09) : 1833 - 1838
  • [79] Efficacy of IVIG affinity-purified anti-double-stranded DNA anti-idiotypic antibodies in the treatment of an experimental murine model of systemic lupus erythematosus
    Shoenfeld, Y
    Rauova, L
    Gilburd, B
    Kvapil, F
    Goldberg, I
    Kopolovic, J
    Rovensky, J
    Blank, M
    [J]. INTERNATIONAL IMMUNOLOGY, 2002, 14 (11) : 1303 - 1311
  • [80] Expansion of cytokine-producing CD4(-)CD8(-) cells associated with abnormal Fas expression and hypereosinophilia
    Simon, HU
    Yousefi, S
    DommannScherrer, CC
    Zimmermann, DR
    Bauer, S
    Barandun, J
    Blaser, K
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (03) : 1071 - 1082
234567891011